Table 4.
Antibiotics susceptibility patterns of isolated bacteria causing bacteriospermia and ESBL producing GNB
| ISOLATES | INT | ANTIBIOTIC SUSCEPTIBILITY PROFILES |
||||||||||||
| AMP n(%) |
SXT n(%) |
AK n(%) |
CIP n(%) |
GEN n(%) |
AMC n(%) |
CRO n(%) |
CAZ n(%) |
TZP n(%) |
MEM n(%) |
E n(%) |
VA n(%) |
CD n(%) |
||
| GNB (N=38) |
R | 38(100%) | 38 (100%) |
2(5.3%) | 5(13.2%) | 9(23.7%) | 35(92.1%) | 15(39.5%) | 11(28.9%) | 3(7.9%) | - | N/A | N/A | N/A |
| I | - | - | 4(10.5%) | 1(2.6%) | 1(2.6%) | 2(5.3%) | 3(7.9%) | 5(13.2%) | 3(7.9%) | - | ||||
| S | - | - | 32(84.2%) | 32(84.2%) | 28(73.7%) | 1(2.6%) | 20(52.6%) | 22(57.9%) | 32(84.2%) | 38(100%) | ||||
| ESBL-GNB (N=12) |
R | 12(100%) | 12(100%) | 2(16.7%) | 2(16.7%) | 8(66.7) | 11(91.7%) | 10(83.3%) | 10(83.3%) | 2(16.7%) | - | N/A | ||
| I | - | - | 1(8.3%) | - | - | 1(8.3%) | 2(16.7%) | 2(16.7%) | 1(8.3%) | - | ||||
| S | - | - | 9(75%) | 10(83.3%) | 4(33.3%) | - | - | - | 9(75%) | 12(100%) | ||||
| GPB (N=6) | R | N/A | N/A | N/A | 1(16.7%) | 2(33.3%) | N/A | N/A | N/A | N/A | N/A | 4(66.7%) | ||
| I | - | 1(16.7%) | 1(16.7%) | - | - | |||||||||
| S | 5(83.3%) | 3(50%) | 1(16.7%) | 6(100%) | 6(100%) | |||||||||
AMP=ampicillin, SXT=cotrimoxazole, AK=amikacin, CIP=ciprofloxacin, GEN=gentamicin, AMC=amoxycillin-clavulanic acid, CRO=ceftriaxone, CAZ=ceftazidime, TZP=piperacillin-tazobactam, MEM=meropenem, E=erythromycin, VA=vancomycin, CD=clindamycin, INT=interpretation, R=resistance, I=intermediate, S=sensitive and NA=not applicable